about
Do CYP2C19 and ABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients?Influence of ABCB1 and CYP3A5 gene polymorphisms on pharmacokinetics of apixaban in patients with atrial fibrillation and acute stroke.Pheno- and genotyping the prescription of drugs metabolized by CYP2D6Interval training early after heart failure decompensation is safe and improves exercise tolerance and quality of life in selected patientsCYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and RivaroxabanEffects of the rs2244613 polymorphism of the CES1 gene on the antiplatelet effect of the receptor P2Y12 blocker clopidogrelThe ABCB1, CYP2C19, CYP3A5 and CYP4F2 genetic polymorphisms and platelet reactivity in the early phases of acute coronary syndromesPrevalence of Atrial Fibrillation and use of Oral Antithrombotic Therapy in Patients with Acute Coronary SyndromeGenotyping and phenotyping CYP3A4\CYP3A5: no association with antiplatelet effect of clopidogrel
P50
Q42731695-7285CB3E-F97B-4D93-9EFD-59A4B25857A1Q52614684-EC53A2EF-19B7-461F-9748-0D3FCEFB10C4Q58874003-6FAB8232-52A6-4C2C-9A8F-ABE0C0A2831AQ88697089-BB1B6FE3-F76A-4505-9997-B4BF8C49E9E7Q90217107-FB017CB6-0CF5-4461-A1F0-92FC80EE7BD0Q90329233-05E4FA6E-A9AA-4910-9AA4-099B70E72A98Q91256571-34049E08-D05E-43F4-BB6E-C5BC9107F45EQ91315627-A1468084-EF2A-4BBE-9E1D-A6511ADB701DQ92127799-A42CBDAE-39C8-48D8-BFDB-B8A48D158A07
P50
description
Forscher
@de
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究員
@ja
研究者
@zh
name
D A Andreev
@en
D A Andreev
@nl
type
label
D A Andreev
@en
D A Andreev
@nl
prefLabel
D A Andreev
@en
D A Andreev
@nl
P106
P31
P496
0000-0002-0276-7374